| Dr Najaf Asrar, MD | |
|
986 Shoppes Blvd, North Brunswick, NJ 08902-2776 | |
| (732) 497-5000 | |
| (732) 497-5001 |
| Full Name | Dr Najaf Asrar |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 10 Years |
| Location | 986 Shoppes Blvd, North Brunswick, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104246149 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Brunswick Medical Associates | 1254595226 | 3 |
| Central Jersey Medical Center Inc. | 1456301241 | 24 |
News Archive
Researchers at Kaiser Permanente have found that patients with a very early form of breast cancer (ductal carcinoma in situ or DCIS) who have higher mammographic density may be at increased risk for subsequent breast cancer, especially in the breast opposite to the one with the initial cancer.
Hospira, Inc., a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, announces the availability of INFLECTRA (infliximab) in Canada, the country's first subsequent entry biologic (SEB) monoclonal antibody (mAb) therapy.
Nanogen has announced that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimer's disease biomarkers.
DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its operating results for the third quarter of 2013.
Increasing evidence has linked autism spectrum disorder with dysfunction of the brain's cerebellum, but the details have been unclear. In a new study, researchers at Boston Children's Hospital used stem cell technology to create cerebellar cells known as Purkinje cells from patients with tuberous sclerosis complex, a genetic syndrome that often includes ASD-like features.
› Verified 9 days ago
| Entity Name | Central Jersey Medical Center Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932974250 PECOS PAC ID: 1456301241 Enrollment ID: O20050712000392 |
News Archive
Researchers at Kaiser Permanente have found that patients with a very early form of breast cancer (ductal carcinoma in situ or DCIS) who have higher mammographic density may be at increased risk for subsequent breast cancer, especially in the breast opposite to the one with the initial cancer.
Hospira, Inc., a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, announces the availability of INFLECTRA (infliximab) in Canada, the country's first subsequent entry biologic (SEB) monoclonal antibody (mAb) therapy.
Nanogen has announced that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimer's disease biomarkers.
DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its operating results for the third quarter of 2013.
Increasing evidence has linked autism spectrum disorder with dysfunction of the brain's cerebellum, but the details have been unclear. In a new study, researchers at Boston Children's Hospital used stem cell technology to create cerebellar cells known as Purkinje cells from patients with tuberous sclerosis complex, a genetic syndrome that often includes ASD-like features.
› Verified 9 days ago
| Entity Name | North Brunswick Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861762197 PECOS PAC ID: 1254595226 Enrollment ID: O20120605000091 |
News Archive
Researchers at Kaiser Permanente have found that patients with a very early form of breast cancer (ductal carcinoma in situ or DCIS) who have higher mammographic density may be at increased risk for subsequent breast cancer, especially in the breast opposite to the one with the initial cancer.
Hospira, Inc., a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, announces the availability of INFLECTRA (infliximab) in Canada, the country's first subsequent entry biologic (SEB) monoclonal antibody (mAb) therapy.
Nanogen has announced that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimer's disease biomarkers.
DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its operating results for the third quarter of 2013.
Increasing evidence has linked autism spectrum disorder with dysfunction of the brain's cerebellum, but the details have been unclear. In a new study, researchers at Boston Children's Hospital used stem cell technology to create cerebellar cells known as Purkinje cells from patients with tuberous sclerosis complex, a genetic syndrome that often includes ASD-like features.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Najaf Asrar, MD 986 Shoppes Blvd, North Brunswick, NJ 08902-2776 Ph: () - | Dr Najaf Asrar, MD 986 Shoppes Blvd, North Brunswick, NJ 08902-2776 Ph: (732) 497-5000 |
News Archive
Researchers at Kaiser Permanente have found that patients with a very early form of breast cancer (ductal carcinoma in situ or DCIS) who have higher mammographic density may be at increased risk for subsequent breast cancer, especially in the breast opposite to the one with the initial cancer.
Hospira, Inc., a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, announces the availability of INFLECTRA (infliximab) in Canada, the country's first subsequent entry biologic (SEB) monoclonal antibody (mAb) therapy.
Nanogen has announced that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimer's disease biomarkers.
DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its operating results for the third quarter of 2013.
Increasing evidence has linked autism spectrum disorder with dysfunction of the brain's cerebellum, but the details have been unclear. In a new study, researchers at Boston Children's Hospital used stem cell technology to create cerebellar cells known as Purkinje cells from patients with tuberous sclerosis complex, a genetic syndrome that often includes ASD-like features.
› Verified 9 days ago
Marcus E Carr Jr., Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 685 Highway Route 1, North Brunswick, NJ 08902 Phone: 732-214-2425 Fax: 609-580-8626 | |
Dae Woo Lee, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 984 Bergen Ave, North Brunswick, NJ 08902 Phone: 732-545-0202 Fax: 732-545-5002 | |
Dr. Bharati Deka, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2090 State Route 27 101, North Brunswick, NJ 08902 Phone: 732-979-0035 | |
Hui Guo, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1254 Route 27, Suite 101, North Brunswick, NJ 08902 Phone: 732-640-2777 Fax: 732-317-8148 | |
Mr. Howard Blau, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1950 Route 27, Suite H, North Brunswick, NJ 08902 Phone: 732-422-2300 Fax: 732-422-3141 | |
Dr. Haritha Potluri, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1440 How Ln, Suite 2d, North Brunswick, NJ 08902 Phone: 732-719-2222 Fax: 732-719-2224 |